These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
76 related items for PubMed ID: 4159768
41. Abnormal chromatographic pattern of gamma-globulin in acute rheumatoid arthritis. Fidalgo BV, Najjar VA, Overall JC. Johns Hopkins Med J; 1967 Aug; 121(2):73-81. PubMed ID: 4166327 [No Abstract] [Full Text] [Related]
43. Inhibition of the anti-globulin reaction by human immunoglobulin G and its fragments. Grob PJ, Isliker HC, Webb T. Immunology; 1967 Mar; 12(3):275-83. PubMed ID: 4164031 [Abstract] [Full Text] [Related]
44. Treatment of chronic idiopathic thrombocytopenic purpura (ITP) with high-dose intravenous gamma globulin. Duran-Suarez JR, Martin A, Botella MC, de la Torre S, Bailen A, Maldonado J. Haematologica; 1983 Mar; 68(4):564-6. PubMed ID: 6195053 [No Abstract] [Full Text] [Related]
45. Deleterious effects of high dose gamma-globulin therapy on patients with hemophagocytic syndrome. Nagasawa M, Okawa H, Yata J. Int J Hematol; 1994 Jul; 60(1):91-3. PubMed ID: 7522617 [No Abstract] [Full Text] [Related]
46. [First experiences with intravenously injectable human gamma globulin of the Dessau Vaccine Research Institute]. Polster H. Dtsch Gesundheitsw; 1968 Oct 03; 23(40):1903-9. PubMed ID: 4183335 [No Abstract] [Full Text] [Related]
47. [Therapy with gamma globulins. When, with what, with what success or risk?]. Seifert J, Duswald KH, Ring J. Fortschr Med; 1980 Apr 10; 98(14):533-8. PubMed ID: 6154635 [No Abstract] [Full Text] [Related]
48. Ultracentrifugal studies of the reactions of rheumatoid factor with native human gamma-G-globulin. Normansell DE, Stanworth DR. Immunology; 1966 Jun 10; 10(6):527-33. PubMed ID: 4161806 [Abstract] [Full Text] [Related]
49. [The effect of ultrasonic waves on isolated A-chains of the molecule of human gamma-globulin]. Zorina OM, Stekol'nikov LI, El'piner IE. Dokl Akad Nauk SSSR; 1966 Apr 11; 167(5):1164-7. PubMed ID: 4172428 [No Abstract] [Full Text] [Related]
50. [Intravenous gamma globulin substitution in humoral immune defects]. Stensvold K, Orognum T, Brandtzaeg P. Tidsskr Nor Laegeforen; 1984 Nov 30; 104(33):2323-5. PubMed ID: 6084325 [No Abstract] [Full Text] [Related]
51. Administration of intravenous iron sucrose as a 2-minute push to CKD patients: a prospective evaluation of 2,297 injections. Macdougall IC, Roche A. Am J Kidney Dis; 2005 Aug 30; 46(2):283-9. PubMed ID: 16112047 [Abstract] [Full Text] [Related]
52. Studies with intravenous gamma globulin. Merler E, Rosen FS, Salmon S, Crain JD, Janeway CA. Vox Sang; 1967 Jul 30; 13(1):102-3. PubMed ID: 4166586 [No Abstract] [Full Text] [Related]
53. [In vivo induction of antibody formation by macrophages sensitized with human gamma globulin in vitro]. Cruchaud A. Bull Schweiz Akad Med Wiss; 1969 Jul 30; 24(5):414-21. PubMed ID: 4193315 [No Abstract] [Full Text] [Related]
54. Turnover of standard-gammaglobulin, pH-4-gammaglobulin and pepsin desaggregated gammaglobulin and clinical implications. Koblet H, Barandun S, Diggelmann H. Vox Sang; 1967 Jul 30; 13(1):93-102. PubMed ID: 4166596 [No Abstract] [Full Text] [Related]